Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||
| Net Income | -1,098 | N/A | -4,081 |
| Depreciation Amortization | 51 | N/A | 43 |
| Accounts payable and accrued liabilities | -478 | N/A | 508 |
| Other Working Capital | -450 | N/A | 529 |
| Other Operating Activity | 526 | 0 | 1,269 |
| Operating Cash Flow | $-1,449 | $N/A | $-1,732 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -107 | N/A | -188 |
| Purchase Sale Intangibles | -18 | N/A | -135 |
| Other Investing Activity | -18 | 0 | -135 |
| Investing Cash Flow | $-125 | $N/A | $-323 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 1,881 |
| Common Stock Issued | N/A | N/A | 1,432 |
| Other Financing Activity | 2,295 | 0 | 0 |
| Financing Cash Flow | $2,295 | $N/A | $3,314 |
| Beginning Cash Position | 6,956 | N/A | 1,689 |
| End Cash Position | 7,678 | N/A | 2,948 |
| Net Cash Flow | $722 | $N/A | $1,259 |
| Free Cash Flow | |||
| Operating Cash Flow | -1,449 | N/A | -1,732 |
| Capital Expenditure | -107 | N/A | -188 |
| Free Cash Flow | -1,555 | 0 | -1,920 |